# Monash University

Organization · id `cardio:org-monash-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 02bfwt286](<https://ror.org/02bfwt286>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 02bfwt286 by an exact name.

## The registry's words

- Sponsor name: Monash University
- Sponsor class: OTHER
- ROR name: Monash University

## Connected pages

- Sponsors: Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF) (`cardio:ct-nct02041130`)
- Sponsors: A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) (`cardio:ct-nct02099123`)
- Sponsors: Intervention for Diabetes With Education, Advancement and Support (`cardio:ct-nct02466880`)
- Sponsors: Trial of EXenatide in Acute Ischaemic Stroke (`cardio:ct-nct03287076`)
- Sponsors: Carnosine for Peripheral Vascular Disease (`cardio:ct-nct03844113`)
- Sponsors: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (`cardio:ct-nct05202509`)
- Sponsors: SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes (`cardio:ct-nct05345327`)
- Sponsors: RECOMMEND Platform Trial (`cardio:ct-nct06526533`)
- Sponsors: Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes. (`cardio:ct-nct06888687`)

## Provenance

Content hash: 56b716e7d409e3dde4438c8d46841667b508d93b5c3ab6cb2a9e2b35930eff0c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
